Axa’s Tenax Therapeutics TENX Stock Holding History

Axa’s Portfolio TENX Stock Details TENX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1	Closed	-$164K	–	1489
2014 Q4	$164K	Buy	+1	New	+$121K	﹤0.01%	1283
2014 Q3	–	Hold	0	–	–	–	1366

Other funds holding TENX

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

OPPM

Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Axa's TENX Position: Q1 2015 in Review

Axa sold out of Tenax Therapeutics (TENX) in Q1 2015, closing a stake of 1 share — an estimated $164K sold.

Axa first reported a position in TENX in Q4 2014 and held it in 1 quarter. The position peaked at $164K in Q4 2014. 16 funds tracked by Wall St. Rank hold TENX as of Q1 2015.

Axa reported no remaining Tenax Therapeutics position as of Q1 2015 after selling out during the quarter.
Axa sold 1 Tenax Therapeutics share in Q1 2015, an estimated $164K.
Axa first reported a position in Tenax Therapeutics in Q4 2014 and held it in 1 quarter.
Axa's Tenax Therapeutics position peaked at $164K in Q4 2014.
16 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2015.

Based on Axa's 13F filing for Q1 2015, filed 13 May 2015.